Current Position: Home >News >Waters... noitazilaicremmoC dna tnempole Full Article

Waters... noitazilaicremmoC dna tnempole

Author: Careers & Partnerships  Source: Research  Views:   [LargeMediumSmall]  Published on: 2025-06-09 18:37:18 Comments:
Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing, and QC scientists